The future key role of LC–high-resolution-MS analyses in clinical laboratories: a focus on quantification

Papers of special note have been highlighted as: ▪ of interest

References

• 1  Himmelsbach M. 10 years of MS instrumental developments – impact on LC–MS/MS in clinical chemistry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.883–884,3–17 (2012).
  Medline CASGoogle Scholar
• 2  Becker S, Kortz L, Helmschrodt C, Thiery J, Ceglarek U. LC–MS-based metabolomics in the clinical laboratory. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.883–884,68–75 (2012).
  Medline CASGoogle Scholar
• 3  Shushan B. A review of clinical diagnostic applications of liquid chromatography–tandem mass spectrometry. Mass Spectrom. Rev.29(6),930–944 (2010).
  Medline CASGoogle Scholar
• 4  Korfmacher WA. Principles and applications of LC–MS in new drug discovery. Drug Discov. Today10(20),1357–1367 (2005).
  Medline CASGoogle Scholar
• 5  Jemal M. High-throughput quantitative bioanalysis by LC–MS/MS. Biomed. Chromatogr.14(6),422–429 (2000).
  Medline CASGoogle Scholar
• 6  Maurer HH. Current role of liquid chromatography–mass spectrometry in clinical and forensic toxicology. Anal. Bioanal. Chem.388(7),1315–1325 (2007).
  Medline CASGoogle Scholar
• 7  LeDoux M. Analytical methods applied to the determination of pesticide residues in foods of animal origin. A review of the past two decades. J. Chromatogr. A1218(8),1021–1036 (2011).
  Medline CASGoogle Scholar
• 8  Williamson LN, Bartlett MG. Quantitative liquid chromatography–time-of-flight mass spectrometry. Biomed. Chromatogr.21(6),567–576 (2007).
  Medline CASGoogle Scholar
• 9  Williamson LN, Zhang G, Terry AV Jr, Bartlett MG. Comparison of time-of-flight mass spectrometry to triple quadrupole tandom mass spectrometry for quantitative bioanalysis: application to antipsychotics. J. Liq. Chromatogr. Relat. Technol.31(18),2737–2751 (2008).
  CASGoogle Scholar
• 10  Wang J, Leung D, Chow W. Applications of LC–ESI-MS/MS and UHPLC QqTOF MS for the determination of 148 pesticides in berries. J. Agric. Food Chem.58(10),5904–5925 (2010).
  Medline CASGoogle Scholar
• 11  Wang J, Chow W, Leung D. Applications of LC/ESI-MS/MS and UHPLC QqTOF MS for the determination of 148 pesticides in fruits and vegetables. Anal. Bioanal. Chem.396(4),1513–1538 (2010).
  Medline CASGoogle Scholar
• 12  Kaufmann A, Butcher P, Maden K, Walker S, Widmer M. Quantitative and confirmative performance of liquid chromatography coupled to high-resolution mass spectrometry compared with tandem mass spectrometry. Rapid Commun. Mass Spectrom.25(7),979–992 (2011).▪ Compare quantification capabilities of high-resolution (HR)-MS and triple-quadrupole (TQ)-MS and shows that HR-MS perform as well as TQ-MS.
  Medline CASGoogle Scholar
• 13  Bateman KP, Kellmann M, Muenster H, Papp R, Taylor L. Quantitative–qualitative data acquisition using a benchtop orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom.20(8),1441–1450 (2009).▪ Presents the advantage of HR-full scan (FS) for quantitative–qualitative workflow for drug and metabolite PK and the fundamental change in how routine bioanalysis is carried out.
  Medline CASGoogle Scholar
• 14  Zhang NR, Yu S, Tiller P, Yeh S, Mahan E, Emary WB. Quantitation of small molecules using high-resolution accurate mass spectrometers – a different approach for analysis of biological samples. Rapid Commun. Mass Spectrom.23(7),1085–1094 (2009).
  Medline CASGoogle Scholar
• 15  Henry H, Sobhi HR, Scheibner O, Bromirski M, Nimkar SB, Rochat B. Comparison between a high-resolution single-stage orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs. Rapid Commun. Mass Spectrom.26(5),499–509 (2012).▪ Shows that HR-MS are performing quantitative analysis as efficiently as TQ-MS and are suitable for routine analysis in clinical laboratories.
  Medline CASGoogle Scholar
• 16  Dillen L, Cools W, Vereyken L et al. Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis4(5),565–579 (2012).
  CASGoogle Scholar
• 17  Ramanathan R, Jemal M, Ramagiri S et al. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. J. Mass Spectrom.46(6),595–601 (2011).▪ One of the first articles focusing on the shift of paradigm in qualitative–quantitative analysis due to recent HR-MS capabilities.
  Medline CASGoogle Scholar
• 18  Wille K, Claessens M, Rappé K et al. Rapid quantification of pharmaceuticals and pesticides in passive samplers using ultra high performance liquid chromatography coupled to high resolution mass spectrometry. J. Chromatogr. A1218(51),9162–9173 (2011).
  Medline CASGoogle Scholar
• 19  Korfmacher W. High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures. Bioanalysis3(11),1169–1171 (2011).
  CASGoogle Scholar
• 20  Kaufmann A. The current role of high-resolution mass spectrometry in food analysis. Anal. Bioanal. Chem.403(5),1233–1249 (2012).
  Medline CASGoogle Scholar
• 21  Weston DJ, Weidolf L. High-resolution MS in drug discovery and development: current applications and future perspectives. Bioanalysis4(5),481–486 (2012).
  CASGoogle Scholar
• 22  Josephs JL. HRMS: current usage, future directions and the promise of integration with unified data streams suited to post-acquisition mining. Bioanalysis4(5),471–476 (2012).
  CASGoogle Scholar
• 23  Scigelova M, Makarov A. Advances in bioanalytical LC–MS using the orbitrap™ mass analyzer. Bioanalysis1(4),741–754 (2009).
  CASGoogle Scholar
• 24  Hopfgartner G, Tonoli D, Varesio E. High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Anal. Bioanal. Chem.402(8),2587–2596 (2012).
  Medline CASGoogle Scholar
• 25  Lu W, Clasquin MF, Melamud E, Amador-Noguez D, Caudy AA, Rabinowitz JD. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. Anal. Chem.82(8),3212–3221 (2010).
  Medline CASGoogle Scholar
• 26  Brenton AG, Godfrey AR,. Accurate mass measurement: terminology and treatment of data. J. Am. Soc. Mass Spectrom.21,1821–1835 (2010).
  Medline CASGoogle Scholar
• 27  Rochat B. Quantitative/qualitative analysis using LC–HRMS: the fundamental step forward for clinical laboratories and clinical practice. Bioanalysis4(14),1709–1711 (2012).
  CASGoogle Scholar
• 28  Sottas PE, Robinson N, Rabin O, Saugy M. The athlete biological passport. Clin. Chem.57(7),969–976 (2011).
  Medline CASGoogle Scholar
• 29  Kaufmann A, Butcher P, Maden K, Walker S, Widmer M. Comprehensive comparison of liquid chromatography selectivity as provided by two types of liquid chromatography detectors (high resolution mass spectrometry and tandem mass spectrometry): “where is the crossover point?” Anal. Chim. Acta673(1),60–72 (2010).▪ Compares the selectivity of ion transitions at unit resolution (TQ-MS) with HR-FS (accurate mass-extracted ion chromatogram).
  Medline CASGoogle Scholar
• 30  Kellmann M, Muenster H, Zomer P, Mol JGJ. Full scan MS in comprehensive qualitative and quantitative residue analysis in food and feed matrices: how much resolving power is required? J. Am. Soc. Mass Spectrom.20(8),1464–1476 (2009).▪ Compares the selectivity of ion transitions at unit resolution (TQ-MS) with HR-FS (accurate mass-extracted ion chromatogram) in different biomatrices and sample clean-up.
  CASGoogle Scholar
• 31  Xia YQ, Lau J, Olah T, Jemal M. Targeted quantitative bioanalysis in plasma using liquid chromatography–high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes. Rapid Commun. Mass Spectrom.25(19),2863–2878 (2011).▪ Shows the importance of the resolution and the mass extraction window in the detection of false-positive signals.
  Medline CASGoogle Scholar
• 32  van der Heeft E, Bolck YJ, Beumer B, Nijrolder AW, Stolker AA, Nielen MW. Full-scan accurate mass selectivity of ultra-performance liquid chromatography combined with time-of-flight and orbitrap mass spectrometry in hormone and veterinary drug residue analysis. J. Am. Soc. Mass Spectrom.20(3),451–463 (2009).
  Medline CASGoogle Scholar
• 33  Rousu T, Tolonen A. Comparison of unit resolution SRM and TOF-MS at 12,000 mass resolution for quantitative bioanalysis of 11 steroids from human plasma. Bioanalysis4(5),555–563 (2012).
  CASGoogle Scholar
• 34  Furlong M, Bessire A, Song W, Huntington C, Groeber E. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography–tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples. Rapid Commun. Mass Spectrom.24(13),1902–1910 (2010).
  Medline CASGoogle Scholar
• 35  Matuszewski BK, Chavez-Eng CM, Constanzer ML. Development of high-performance liquid chromatography–tandem mass spectrometric methods for the determination of a new oxytocin receptor antagonist (L-368,899) extracted from human plasma and urine: a case for lack of specificity due to the presence of metabolites. J. Chromatogr. B Biomed. Sci. Appl.716(1–2),195–208 (1998).
  Medline CASGoogle Scholar
• 36  Majumdar TK, Vedananda S, Tse FL. Rapid analysis of MMI270B, an inhibitor of matrix metalloproteases in human plasma by liquid chromatography–tandem mass spectrometry: matrix interference in patient samples. Biomed. Chromatogr.18(2),77–85 (2004).
  Medline CASGoogle Scholar
• 37  Jamel M, Xia YQ. The need for adequate chromatographic separation in the quantitative determination of drugs in biological samples by high performance liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom.13(2),97–106 (1999).
  Google Scholar
• 38  Piraud M, Vianey-Saban C, Petritis K et al. ESI-MS/MS analysis of underivatised amino acids: a new tool for the diagnosis of inherited disorders of amino acid metabolism. Fragmentation study of 79 molecules of biological interest in positive and negative ionisation mode. Rapid Commun. Mass Spectrom.17(12),1297–1311 (2003).
  Medline CASGoogle Scholar
• 39  Shah V, Midha K, Findlay J et al. Bioanalytical method validation – a revisit with a decade of progress. Pharm. Res.17(12),1551–1557 (2000).
  Medline CASGoogle Scholar
• 40  US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation. Rockville, MD, USA (2001).
  Google Scholar
• 41  Shah VP, Bansal S. Historical perspective on the development and evolution of bioanalytical guidance and technology. Bioanalysis3(8),823–827 (2011).
  CASGoogle Scholar
• 42  Fung EN, Xia YQ, Aubry AF, Zeng J, Olah T, Jemal M. Full-scan high resolution accurate mass spectrometry (HRMS) in regulated bioanalysis: LC–HRMS for the quantitation of prednisone and prednisolone in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.879(27),2919–2927 (2011).
  Medline CASGoogle Scholar
• 43  Schwaninger AE, Meyer MR, Huestis MA, Maurer HH. Development and validation of LC–HRMS and GC–NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine. J. Mass Spectrom.46(7),603–614 (2011).
  Medline CASGoogle Scholar
• 44  Vogliardi S, Favretto D, Tucci M, Stocchero G, Ferrara SD. Simultaneous LC–HRMS determination of 28 benzodiazepines and metabolites in hair. Anal. Bioanal. Chem.400(1),51–67 (2011).
  Medline CASGoogle Scholar
• 45  Bekaert KM, Van den Bussche J, François S et al. A validated ultra-high performance liquid chromatography coupled to high resolution mass spectrometry analysis for the simultaneous quantification of the three known boar taint compounds. J. Chromatogr. A1239,49–55 (2012).
  Medline CASGoogle Scholar
• 46  Grange AH, Sovocool GW. Automated determination of precursor ion, product ion, and neutral loss compositions and deconvolution of composite mass spectra using ion correlation based on exact masses and relative isotopic abundances. Rapid Commun. Mass Spectrom.22(15),2375–2390 (2008).
  Medline CASGoogle Scholar
• 47  Xu Y, Heilier JF, Madalinski G et al. Evaluation of accurate mass and relative isotopic abundance measurements in the LTQ-orbitrap mass spectrometer for further metabolomics database building. Anal. Chem.82(13),5490–5501 (2010).
  Medline CASGoogle Scholar
• 48  Kind T, Fiehn O. Seven golden rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics8,105–124 (2007).
  MedlineGoogle Scholar
• 49  Zhang H, Zhang D, Ray K, Zhu M. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. J. Mass Spectrom.44(7),999–1016 (2009).
  Medline CASGoogle Scholar
• 50  Ramanathan R, Josephs JL, Jemal M, Arnold M, Humphreys WG. Novel MS solutions inspired by MIST. Bioanalysis2(7),1291–1313 (2010).
  CASGoogle Scholar
• 51  Yang Y, Grubb MF, Luk CE, Humphreys WG, Josephs JL. Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography–high resolution accurate mass spectrometry in combination with UV correction. Rapid Commun. Mass Spectrom.25(21),3245–3251 (2011).
  Medline CASGoogle Scholar
• 52  Johnson CH, Patterson AD, Idle JR, Gonzalez FJ. Xenobiotic metabolomics: major impact on the metabolome. Annu. Rev. Pharmacol. Toxicol.52,37–56 (2012).
  Medline CASGoogle Scholar
• 53  Psychogios N, Hau DD, Peng J et al. The human serum metabolome. PLoS ONE6(2),e16957 (2011).
  Medline CASGoogle Scholar
• 54  Dunn WB, Broadhurst D, Begley P et al. Human serum metabolome (HUSERMET) consortium. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc.6(7),1060–1083 (2011).
  Medline CASGoogle Scholar
• 55  Lawton KA, Berger A, Mitchell M et al. Analysis of the adult human plasma metabolome. Pharmacogenomics9(4),383–397 (2008).
  Medline CASGoogle Scholar
• 56  Koulman A, Woffendin G, Narayana VK, Welchman H, Crone C, Volmer DA. High-resolution extracted ion chromatography, a new tool for metabolomics and lipidomics using a second-generation orbitrap mass spectrometer. Rapid Commun. Mass Spectrom.23(10),1411–1418 (2009).
  Medline CASGoogle Scholar
• 57  Vuckovic D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry. Anal. Bioanal. Chem.403(6),1523–1548 (2012).
  Medline CASGoogle Scholar
• 58  Phapale PB, Kim SD, Lee HW et al. An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus. Clin. Pharmacol. Ther.87(4),426–436 (2010).
  Medline CASGoogle Scholar
• 59  Wikoff WR, Anfora AT, Liu J et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA106,3698–3703 (2009).
  Medline CASGoogle Scholar
• 60  Martin FP, Collino S, Rezzi S, Kochhar S. Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front. Physiol.3,113 (2012).
  Medline CASGoogle Scholar
• 61  Collino S, Martin FP, Rezzi S. Clinical metabolomics paves the way towards future healthcare strategies. Br. J. Clin. Pharmacol. doi:10.1111/j.1365-2125.2012.04216.x. (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 62  Zhang A, Sun H, Wang X. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal. Bioanal. Chem.404(4),1239–1245 (2012).
  Medline CASGoogle Scholar
• 63  Schmerler D, Neugebauer S, Ludewig K, Bremer-Streck S, Brunkhorst FM, Kiehntopf M. Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J. Lipid Res.53(7),1369–1375 (2012).
  Medline CASGoogle Scholar
• 64  Monte AA, Heard KJ, Vasiliou V. Prediction of drug response and safety in clinical practice. J. Med. Toxicol.8(1),43–51 (2012).
  MedlineGoogle Scholar
• 65  Patterson AD, Maurhofer O, Beyoglu D et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res.71(21),6590–6600 (2011).
  Medline CASGoogle Scholar
• 101  Scripps Center for Metabolomics. METLIN: Metabolite and Tandem MS Database. http://metlin.scripps.edu
  Google Scholar
• 102  Human Metabolome Database. www.hmdb.ca
  Google Scholar
• 103  High Quality Mass Spectral Database. www.massbank.jp
  Google Scholar